Medicare Enrolled
Dr. Ali Lakhani, MD
Hematology & Oncology · Joliet, IL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Lakhani from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lakhani?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Lakhani
Dr. Ali Lakhani is a hematology & oncology specialist in Joliet, IL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Lakhani performed 43,367 Medicare services across 3,048 unique beneficiaries.
Between the years covered by Open Payments, Dr. Lakhani received a total of $13,990 from 92 pharmaceutical and/or device companies across 688 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Lakhani is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 23% volume in IL
$13,990 industry payments
Medicare Practice Summary
Medicare Utilization ↗43,367
Medicare services
Top 23% in IL for hematology & oncology
3,048
Unique beneficiaries
$7
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~2,168 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
21,420 | $0 | $3 |
| Anti-nausea injection (fosaprepitant) An injection of fosaprepitant, a medication used to prevent nausea and vomiting. |
7,350 | $0 | $3 |
| Denosumab injection (Prolia/Xgeva) | 4,620 | $18 | $27 |
| Epoetin alfa injection (Retacrit) for anemia An injection of a biosimilar form of epoetin alfa used for non-end-stage renal disease purposes. The dose administered is 1000 units. |
1,820 | $6 | $22 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,168 | $0 | $1 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
753 | $8 | $20 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
734 | $8 | $40 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
676 | $10 | $55 |
| Anti-nausea injection (Aloxi/palonosetron) | 560 | $1 | $142 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
438 | $98 | $229 |
| Lactate dehydrogenase (LDH) level test A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease. |
346 | $6 | $30 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
316 | $13 | $54 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
239 | $11 | $62 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
200 | $13 | $70 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
189 | $106 | $380 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
185 | $137 | $307 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
178 | $65 | $151 |
| Prothrombin time test (blood clotting) A laboratory test that measures how long it takes for blood to clot. This procedure evaluates the body's coagulation process. |
165 | $4 | $20 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
160 | $96 | $218 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
156 | $50 | $201 |
| Methylprednisolone injection, up to 125 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, with a dosage of up to 125 mg. |
119 | $4 | $15 |
| Immunoglobulin level test A blood test that measures the level of gammaglobulins, which are immune system proteins. |
100 | $9 | $48 |
| New patient office visit, complex (60-74 min) | 100 | $167 | $443 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
97 | $24 | $95 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
97 | $1 | $3 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
96 | $23 | $95 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
94 | $60 | $202 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
91 | $139 | $431 |
| Iron level test | 90 | $6 | $33 |
| Iron binding capacity test A blood test that measures the amount of iron in the blood and the blood's ability to bind and transport iron. |
90 | $9 | $45 |
| Vitamin B-12 level test A blood test that measures the amount of vitamin B-12 in your body. |
64 | $15 | $77 |
| Folic acid level test A blood test that measures the amount of folic acid in the serum. |
64 | $14 | $77 |
| Coagulation function measurement, d-dimer; quantitative | 64 | $10 | $52 |
| Beta-2 microglobulin level test A blood test that measures the level of beta-2 microglobulin, a protein produced by cells in the body. |
61 | $16 | $83 |
| Autoimmune disorder screening test A laboratory test used to screen for the presence of autoimmune disorders. |
61 | $12 | $62 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
58 | $1 | $15 |
| Manual white blood cell count A laboratory test that involves examining a sample under a microscope to manually count the number of white blood cells present. |
49 | $4 | $18 |
| Complete blood count (CBC), automated An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood. |
49 | $6 | $33 |
| Carcinoembryonic antigen (CEA) level test A blood test that measures the level of carcinoembryonic antigen (CEA) protein. This test is used to monitor certain types of cancer. |
45 | $19 | $97 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
37 | $41 | $83 |
| Automated red blood cell count An automated laboratory test that measures the number of red blood cells in a blood sample. |
32 | $4 | $21 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
29 | $17 | $67 |
| Magnesium level test A blood test to measure the amount of magnesium in your body. This helps check for magnesium deficiency or excess. |
25 | $7 | $34 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
25 | $54 | $189 |
| Phosphate level test A blood test that measures the amount of phosphate in your body. Phosphate is a mineral that helps keep bones and teeth strong. |
22 | $5 | $25 |
| Sed rate test (inflammation marker) This automated test measures how quickly red blood cells settle in a tube to detect inflammation in the body. |
20 | $3 | $14 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
15 | $23 | $95 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
50.5% high complexity
38.2% medium
11.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$13,990
Total received (2018-2024)
Avg $1,999/year across 7 years
Top 26% in IL for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
92
Companies
688
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,959 (92.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,031 (7.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,928
2023
$3,046
2022
$1,729
2021
$2,408
2020
$1,559
2019
$1,837
2018
$1,482
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$248
PFIZER INC.
$225
Astellas Pharma US Inc
$166
ABBVIE INC.
$117
Genentech USA, Inc.
$94
Janssen Biotech, Inc.
$89
BeiGene USA, Inc.
$88
Takeda Pharmaceuticals U.S.A., Inc.
$62
Celgene Corporation
$59
EMD Serono, Inc.
$52
Lilly USA, LLC
$50
GENZYME CORPORATION
$49
AstraZeneca Pharmaceuticals LP
$46
Bayer Healthcare Pharmaceuticals Inc.
$46
Gilead Sciences, Inc.
$42
Regeneron Healthcare Solutions, Inc.
$37
Ipsen Biopharmaceuticals, Inc
$35
E.R. Squibb & Sons, L.L.C.
$33
Merck Sharp & Dohme LLC
$32
Mirati Therapeutics, Inc.
$29
JAZZ PHARMACEUTICALS INC.
$29
Genmab U.S., Inc.
$28
Pharmacosmos Therapeutics Inc.
$24
Amneal Pharmaceuticals LLC
$24
BTG International, Inc.
$24
Exelixis Inc.
$23
TAIHO ONCOLOGY, INC.
$22
TerSera Therapeutics LLC
$22
Invivyd Inc
$21
Dendreon Pharmaceuticals LLC
$20
Daiichi Sankyo Inc.
$19
Incyte Corporation
$16
PUMA BIOTECHNOLOGY, INC.
$16
Tempus AI, Inc
$15
GlaxoSmithKline, LLC.
$13
Eisai Inc.
$13
Top 3 companies account for 33.2% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$1,046
E.R. Squibb & Sons, L.L.C.
$936
AstraZeneca Pharmaceuticals LP
$759
Genentech USA, Inc.
$646
Janssen Biotech, Inc.
$614
PFIZER INC.
$503
Merck Sharp & Dohme Corporation
$499
Incyte Corporation
$448
Lilly USA, LLC
$434
Astellas Pharma US Inc
$413
Celgene Corporation
$390
Exelixis Inc.
$387
Merck Sharp & Dohme LLC
$383
Pharmacyclics LLC, An AbbVie Company
$297
JAZZ PHARMACEUTICALS INC.
$294
Takeda Pharmaceuticals U.S.A., Inc.
$289
Eisai Inc.
$276
GENZYME CORPORATION
$264
Seagen Inc.
$263
EMD Serono, Inc.
$239
AbbVie Inc.
$223
Ipsen Biopharmaceuticals, Inc
$202
Global Blood Therapeutics, Inc.
$195
Bayer HealthCare Pharmaceuticals Inc.
$187
Regeneron Healthcare Solutions, Inc.
$187
ABBVIE INC.
$176
EISAI INC.
$174
Daiichi Sankyo Inc.
$174
Deciphera Pharmaceuticals Inc.
$169
AbbVie, Inc.
$164
Amgen Inc.
$156
Gilead Sciences, Inc.
$153
BeiGene USA, Inc.
$147
TerSera Therapeutics LLC
$106
Mirati Therapeutics, Inc.
$102
Rigel Pharmaceuticals, Inc.
$100
Jazz Pharmaceuticals Inc.
$98
G1 Therapeutics, Inc.
$87
Kite Pharma, Inc.
$83
Janssen Pharmaceuticals, Inc
$83
GlaxoSmithKline, LLC.
$79
Coherus Biosciences Inc.
$79
Puma Biotechnology, Inc.
$78
Alexion Pharmaceuticals, Inc.
$75
Pharmacyclics LLC, an AbbVie Company
$72
Boehringer Ingelheim Pharmaceuticals, Inc.
$64
Verastem, Inc.
$56
Dendreon Pharmaceuticals LLC
$52
Dova Pharmaceuticals
$49
Bayer Healthcare Pharmaceuticals Inc.
$46
AMAG Pharmaceuticals, Inc.
$45
EUSA Pharma (US) LLC
$41
Stemline Therapeutics Inc.
$41
Pharmacosmos Therapeutics Inc.
$40
ARRAY BIOPHARMA INC
$38
TAIHO ONCOLOGY, INC.
$37
TESARO, Inc.
$33
Alnylam Pharmaceuticals Inc.
$32
Kyowa Kirin, Inc.
$31
Acrotech Biopharma LLC
$30
Genmab U.S., Inc.
$28
Karyopharm Therapeutics Inc.
$27
Taiho Oncology, Inc.
$26
Amneal Pharmaceuticals LLC
$24
BTG International, Inc.
$24
Blueprint Medicines Corporation
$24
Lexicon Pharmaceuticals, Inc.
$24
Sun Pharmaceutical Industries Inc.
$24
CTI BioPharma Corp.
$23
Novo Nordisk Inc
$23
Epizyme, Inc.,
$23
ADC Therapeutics America, Inc.
$21
Innate Pharma, Inc
$21
Invivyd Inc
$21
Agios Pharmaceuticals, Inc.
$20
CARDINAL HEALTH 414 LLC
$20
Progenics Pharmaceuticals, Inc.
$20
Midatech Pharma US Inc
$19
Myriad Genetic Laboratories, Inc.
$19
Spectrum Pharmaceuticals Inc.
$19
Acceleron Pharma, Inc.
$18
Sysmex Inostics Inc
$18
Secura Bio, Inc.
$18
Verity Pharmaceuticals Inc.
$16
PUMA BIOTECHNOLOGY, INC.
$16
Helsinn Therapeutics (U.S.), Inc.
$15
Tempus AI, Inc
$15
Clovis Oncology, Inc.
$14
Aurobindo Pharma USA, Inc.
$13
Mylan Institutional Inc.
$12
Medtronic USA, Inc.
$12
Nestle HealthCare Nutrition Inc.
$11
Top 3 companies account for 19.6% of all-time payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · AKYNZEO · ALIMTA · ALUNBRIG · AVASTIN · AYVAKIT · Abraxane · Alecensa · Aliqopa · Avastin · BAVENCIO · BOSULIF · BRAFTOVI · BRUKINSA · Balversa · Bavencio · CABLIVI · CABOMETYX · CALQUENCE · CARVYKTI · CEREZYME · COPIKTRA · COSELA · CYRAMZA · Cabometyx · Copiktra · DARZALEX · Doptelet · ELIQUIS · EMPLICITI · ENHERTU · EPKINLY · ERBITUX · ERLEADA · Enhertu · Epkinly · Erleada · FERAHEME · Folotyn · GAUCHER-DISEASE · GAZYVA · GILOTRIF · GIVLAARI · HEMADY · Halaven · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · Imbruvica · Itovebi · JADENU · JAKAFI · JEMPERLI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · Lumoxiti · Lunsumio · MEKINIST · MONJUVI · MVASI · Marqibo · Monoferric · NERLYNX · NINLARO · Nerlynx · Neulasta · Nplate · Nubeqa · OJJAARA · ONUREG · OPDIVO · OPDUALAG · OSTEOCOOL RF ABLATION · OXBRYTA · Onivyde · Orserdu · PADCEV · PEMAZYRE · PEMGARDA · PIQRAY · PLUVICTO · POTELIGEO · PROMACTA · PROVENGE · PYLARIFY · PYRUKYND · Padcev · Polivy · Pomalyst · QINLOCK · QUZYTTIR · REBLOZYL · REMICADE · RETEVMO · Reblozyl · Revlimid · Rezlidhia · Rubraca · SANCUSO · SARCLISA · SCEMBLIX · SOMATULINE DEPOT · SUTENT · Somatuline Depot · Sylvant · TABRECTA · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TEPMETKO · TUKYSA · Tavalisse · Tazverik · Tecentriq · Trelstar · Trodelvy · ULTOMIRIS · Udenyca · Ultomiris · VENCLEXTA · VERZENIO · VYXEOS · Venclexta · Vistogard · Vitrakvi · Vonjo · XARELTO · XERMELO · XPOVIO · XTANDI · Xermelo · Xofigo · Xtandi · YONSA · Yescarta · ZEJULA · ZENPEP · ZEPZELCA · ZYTIGA · Zoladex · Zuplenz · myRisk
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (93%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Hematology & oncology specialists within 10 mi
92
Per 100K population
13.2
County median income
$107,799
Nearest hospital
SAINT JOSEPH MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Lakhani is a mixed practice specialist, with above-average Medicare volume (top 23% in IL), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Lakhani experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Lakhani performed 21,420 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Lakhani receive payments from pharmaceutical companies?
Yes. Dr. Lakhani received a total of $13,990 from 92 companies across 688 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lakhani's costs compare to other hematology & oncology specialists in Joliet?
Dr. Lakhani's average Medicare payment per service is $7. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lakhani) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Joliet
Browse hematology & oncology specialists in Joliet ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in IL
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in IL
Which IL hematology & oncology specialists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology